Screener
Surgery Partners, Inc. SGRY Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Surgery Partners, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: Surgery Partners, Inc.’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001638833-26-000077
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Payments of debt issuance costs | (0.4) | — |
| Distributions to non-controlling interest holders | (103.5) | (116.3) |
| Proceeds related to ownership transactions with non-controlling interest holders | 3.0 | 3.1 |
| Other financing activities | 0.1 | (2.0) |
| Net cash provided by (used in) financing activities | (61.0) | (32.4) |
| Net increase (decrease) in cash and cash equivalents | (23.2) | (19.4) |
| Cash and cash equivalents at beginning of period | 239.9 | 269.5 |
| Cash and cash equivalents at end of period | $216.7 | $250.1 |
Item 1. Financial Statements
FAQ
- What is Surgery Partners, Inc.'s financing cash flow?
- Surgery Partners, Inc. (SGRY) reported financing cash flow of -$5.1M in Q2 2026.
- How has Surgery Partners, Inc.'s financing cash flow changed year-over-year?
- Surgery Partners, Inc.'s financing cash flow increased by 91.9% year-over-year, from -$62.6M to -$5.1M.
- What is the long-term trend for Surgery Partners, Inc.'s financing cash flow?
- Over 2 years (2022 to 2024), Surgery Partners, Inc.'s financing cash flow has grown at a 152.9% compound annual growth rate (CAGR), from $42.1M to $269.3M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about Surgery Partners, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude